Product How it works Pricing Blog FAQ About Contact
Iradimed

Iradimed (NASDAQ: IRMD) dividends paid

Iradimed paid $15.0m in dividends in fiscal 2025, 10.0% more than in fiscal 2024 ($13.7m). That was 66.9% of its net income for the year. It is the total cash paid according to its cash flow statement, not the dividend per share.

Dividends paid, in millions of US dollars12.6202213.2202313.7202415.02025

Dividends paid by fiscal year

Fiscal yearDividends paidChangePayout ratio
2025$15.0m+10.0%66.9%
2024$13.7m+3.4%71.1%
2023$13.2m+5.3%76.9%
2022$12.6m—97.9%

The figure for each fiscal year is the total cash paid in dividends according to the cash flow statement in the annual accounts. It is not the dividend per share and may include amounts paid to minority shareholders of subsidiaries. It covers closed fiscal years and is not a forecast. The change compares each fiscal year with the one before and is not shown when the amount paid is more than ten times the previous one. The payout ratio divides dividends paid by net income for the same fiscal year and is not calculated when net income was not positive. Figures are in millions of US dollars.

Questions about the dividends of Iradimed

How much did Iradimed pay in dividends in fiscal 2025?
Iradimed paid $15.0m in dividends in fiscal 2025, according to its cash flow statement; in fiscal 2024 it paid $13.7m.
What share of its profit did Iradimed pay out?
In fiscal 2025 dividends paid were 66.9% of its net income, which was $22.5m.
In which year did Iradimed pay the most in dividends?
Of its last 4 fiscal years with the figure, fiscal 2025, with $15.0m paid in dividends.
Where do the figures for Iradimed come from?
From the annual report (Form 10-K) that Iradimed files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Iradimed files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022. More on Iradimed: the Iradimed page · annual accounts · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.